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Abstract
Objective—To determine the impact of varying ADHD diagnostic criteria, including new 
DSM-5 criteria, on prevalence estimates.
Method—Parent and teacher reports identified ADHD high and low screen children from 
elementary schools in two states that produced a diverse overall sample. The parent interview 
stage included the Diagnostic Interview Schedule for Children – IV (DISC-IV), and up to four 
additional follow-up interviews. Weighted prevalence estimates, accounting for complex 
sampling, quantified the impact of varying ADHD criteria using baseline and the final follow-up 
interview data.
Results—At baseline 1060 caregivers were interviewed; 656 had at least one follow-up 
interview. Teachers and parents reported six or more ADHD symptoms for 20.5% (95% CI: 
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18.1%–23.2%) and 29.8% (CI: 24.5%–35.6%) of children respectively, with criteria for 
impairment and onset by age seven (DSM-IV) reducing these proportions to 16.3% (CI: 14.7%–
18.0%) and 17.5% (CI: 13.3%–22.8%); requiring at least four teacher-reported symptoms reduced 
the parent-reported prevalence to 8.9% (CI: 7.4%–10.6%). Revising age of onset to 12 years per 
DSM-5 increased this estimate to 11.3% (CI: 9.5%–13.3%), with a similar increase seen at follow-
up: 8.2% with age seven onset (CI: 5.9%–11.2%) versus 13.0% (CI: 7.6%–21.4%) with onset by 
age 12. Reducing the number of symptoms required for those aged 17 and older increased the 
estimate to 13.1% (CI: 7.7%–21.5%).
Conclusion—These findings quantify the impact on prevalence estimates of varying case 
definition criteria for ADHD. Further research of impairment ratings and data from multiple 
informants is required to better inform clinicians conducting diagnostic assessments. DSM-5 
changes in age of onset and number of symptoms required for older adolescents appear to increase 
prevalence estimates, although the full impact is uncertain due to the age of our sample.
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I. Introduction
Attention-Deficit/Hyperactivity Disorder (ADHD) is described as the most common 
neurodevelopmental disorder of childhood;1,2 however, prevalence estimates vary, given 
their sensitivity to factors such as the period of study,3 country or region of the country,3–6 
and research methods,7,8 though a recent meta-analysis has disputed the variability for 
studies using standardized procedures over time.9 In the U.S., rates are higher in the South 
and Midwest;3 however, even where prevalence estimates vary across regions, trends may 
be similar. Different study settings result in varying estimates, with clinic-based studies 
differing from community-based studies in both prevalence and case mix. The direction of 
differences depends on the denominator used for clinical studies, but clinic-based studies 
tend to reflect more severe cases with greater comorbidity.10–13 Additionally, studies using 
different methods and case definitions, such as those that utilize administrative data and 
parent surveys, report different point estimates, yet similar upward trends in the prevalence 
of ADHD;14,15 however, once sample selection parameters are made comparable, estimates 
may become similar.16
ADHD terminology and criteria have undergone substantial revision over time starting with 
Hyperkinetic Reaction of Childhood in the Diagnostic and Statistical Manual of Mental 
Disorders (DSM) 2nd edition, then Attention Deficit Disorder with or without hyperactivity 
in DSM-III.17 In DSM-III-R, subtypes were removed and the diagnosis was ADHD, without 
further specification.18 Three subtypes were created in DSM-IV (inattentive, hyperactive/
impulsive, and combined), reframed as presentation specifiers in DSM-5.1,19,20
Alongside changing terminology, diagnostic criteria have changed over DSM’s four 
revisions with direct impact on diagnosis and estimates of prevalence. The most marked 
changes occurred with the more clearly described disorder of inattentiveness with or without 
hyperactivity in DSM-III,17 followed by delineated subtypes in DSM-IV.19 The impact of 
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modifications to the ADHD criteria in DSM-51 has yet to be realized; particularly with 
regard to age of onset and criteria for older adolescents and adults, though a recent study 
examined the change in age of onset in a cross-sectional national sample and concluded 
increased case finding with comparable clinical significance validated the change.21 Due to 
the variability in prevalence across study types and settings noted above, investigations of 
the impact of case definition on prevalence estimates is important.
In DSM-IV and DSM-5, ADHD diagnosis requires meeting symptom count criteria and 
exhibiting impaired functioning in at least two settings. DSM-IV stated there must be “some 
impairment” related to the symptoms in two or more settings and that there must be “clear 
evidence of clinically significant impairment”. DSM-IV noted that clinicians should obtain 
information from multiples sources. DSM-5 requires that several symptoms22 be present 
before age 12, that they be evident in more than one setting, and that they impair 
functioning. DSM-5 asserts that reliably ascertaining symptoms and impairment in multiple 
settings would be difficult without multiple informants, but both editions stop short of 
explicitly requiring multiple informants. The challenges of collecting data from multiple 
informants include the difficulty of obtaining information from teachers, while respecting 
privacy concerns, regulations, and time constraints, as well as the difficulty of resolving 
disagreement between informants,23,24 raising concerns about the value of investing 
resources in obtaining data from other informants. Depending on how information is 
combined, diagnostic rates and prevalence estimates could increase or be attenuated. 
Barkley25(p. 91) pointed out that DSM-IV criteria “confound settings with sources of 
information”, and that impairment is the important clinical issue to be ascertained, rather 
than agreement among informants.
Further, standard research instruments do not couch impairment classification in the terms 
used in DSM-IV criteria, namely, “clinically significant impairment”, instead using terms 
such as “moderate” and “severe”, as in DSM-5. Translating the level of impairment reported 
in research data to comparable thresholds for DSM classification has been a challenge. Just 
as there is no standard for assessing the level of impairment for research diagnostic 
classification, neither is there a standard metric for clinicians to use in determining level of 
impairment, especially with the deletion of the Global Assessment of Functioning from 
DSM-5, which previously served as a common measure of functional impairment.
Another major change in DSM-5 was the increase in the age of onset criterion, which was 
raised from age seven to 12. The age of onset requirement has been questioned for some 
time, especially because the inattentive symptoms may be delayed in presentation or more 
difficult to identify, particularly among females.10,26–28 Understanding the impact of the 
change in the age of onset criterion is critical for understanding trends in reported ADHD 
prevalence over the next generation of studies.21
DSM-5 also provides more guidance on diagnosis of ADHD among teens and adults 17 
years of age and older, including reducing the number of symptoms required from six to five 
for that group. If prevalence estimates in adults change, the challenge will be to disentangle 
(a) age effects (i.e., adolescents newly meeting or no longer meeting criteria as a result of 
development or treatment) from (b) period effects (i.e., the expanded guidance for adult 
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diagnosis in DSM-5) and from (c) cohort effects (i.e., children and adolescents from later 
cohorts with higher prevalence rates aging into adulthood).
These issues of variability in prevalence estimates are important because they impact 
research methodology and clinical practice with regard to diagnosis and treatment. Further, 
continued wide variability in research reports and in clinical diagnosis can undermine public 
confidence in reports of ADHD research, delaying their impact or reducing their utility for 
informing policy and programs.
In light of the foregoing, the objective of this paper is to quantify the impact of varying case 
definition criteria on prevalence estimates, with focus on symptom and impairment criteria, 
reliance on two informants for multiple settings, and age of onset. Our primary hypothesis is 
that each successive additional requirement will result in a clinically meaningful decrease in 
the proportion classified as having probable ADHD. A secondary objective is to estimate the 
impact on prevalence estimates of the DSM-5 criterion regarding age of onset for impairing 
symptoms and reduced number of required symptoms for those aged 17 and older. Our 
secondary hypothesis is that higher age of onset and lower symptom count for older 
adolescents and adults will result in more participants meeting diagnostic criteria, thus 
increasing the prevalence of diagnosed ADHD. We examined these issues using data from 
the longitudinal Project to Learn about ADHD in Youth.29
II. Methods
Population
The Project to Learn about ADHD in Youth (PLAY) is a community-based epidemiological 
study to characterize the prevalence and impact of ADHD in school-aged children. Methods 
and demographic characteristics of the districts and screened sample by site have been 
previously described.29 Briefly, study participants were selected from public elementary 
schools in school districts in South Carolina and Oklahoma using a stratified, two-stage 
sampling design to maximize case-finding and recruit comparable ratios of boys to girls 
within high and low screen groups. The first stage involved parent and teacher screening in 
mainstream classrooms (SC N=4,606; OK N=12,626). Parents were asked if their child had 
ever been diagnosed with ADHD/ADD and if their child was on medication for ADHD/
ADD. For each child, teachers completed the Vanderbilt ADHD Diagnostic Teacher Rating 
Scale (VADTRS)30 in all six school districts and the Strengths and Difficulties 
Questionnaires (SDQ)31 in four districts. Teachers were also asked two questions about 
diagnosis and treatment for each child, comparable to those asked of parents. Screening 
excluded students in self-contained special education classrooms and included kindergarten 
through 5th grade, with a small number of pre-K students (n=21 in SC and n=37 in OK).
Students with positive responses to the diagnosis and treatment questions from either parent 
or teacher or whose teachers endorsed at least six inattentive or six hyperactive/impulsive 
descriptors on the VADTRS and were rated as having at least some impairment on the SDQ 
or VADTRS were classified as high screen. SDQ data were used where present to determine 
teacher-reported impairment. For the two OK districts that did not administer the SDQ, 
VADTRS performance items were used due to good agreement of impairment classification 
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between the SDQ and the VADTRS (based on 86.5% of the sample who had both: κ=0.68). 
A low screen group was randomly selected from remaining screened students, with 
proportions by gender equal to proportions in the high screen group. These students 
constituted the pool eligible for in-depth interviews.
For most children the participating interviewee was the child’s mother (94% in SC, 86% in 
OK). Data from child interviews were not considered for this report. Interviews included 
selected modules from the Diagnostic Interview Schedule for Children, version IV (DISC-
IV).32 DISC-IV computer algorithms for probable diagnosis were supplemented by 
additional criteria in initial estimates of ADHD prevalence.29 The case definition required at 
least two moderate or one severe rating of impairment across six domains. In addition, to 
meet our ADHD case definition, low screen students had to exhibit at least four teacher-
reported symptoms of hyperactivity/impulsivity or inattention as confirmation symptoms 
were present and problematic in the school setting. Studies at both sites were approved by 
their respective Institutional Review Boards.
Participants with baseline interviews were eligible for up to four follow-up interview waves 
in SC and up to two waves in OK beginning approximately four years after the baseline 
interview wave. Follow-up interviews included the parent and child DISC-IV and parent 
Vanderbilt ADHD Diagnostic Rating Scale and SDQ, as well as additional assessments. 
Among respondents 78% in SC (n=373) and 49% in OK (n=283) completed at least one 
follow-up interview. The median time between baseline interview and last follow-up 
interview was 6.2 years in SC (interquartile range: 5.6–6.6) and 4.2 years in OK (3.1–5.0). 
The last follow-up interview for each child is used in these analyses in order to examine the 
impact of changes to DSM criteria in an older cohort of children (OK median age=13: range 
7–18; SC median age=15: range 7–19; overall median age=14).
Weights were developed at each wave that reflected initial participation in the screening, 
stratified sampling, and non-response over time.29 Analyses were conducted in SAS 9.2 
(SAS Institute, Inc., Cary, NC) and SAS-callable SUDAAN 11.0 (RTI International, 
Research Triangle Park, NC) to account for the sampling design and weighting. The 
weighted population reflected the composition of the school districts with respect to race, 
gender, distribution across schools, and screening status at the time of the baseline 
interview. For a longitudinal analysis of symptom persistence and factors associated with 
elevated symptom counts, see Holbrook et al.33
Variations in Case Definition
The project case definition was based on the DISC algorithms, with additional requirements 
reflecting our interpretation of DSM-IV criteria. Those criteria were formulated a priori and 
previously reported.29 For this report, data from initial teacher and parent screens 
concerning diagnosis and treatment, teacher report of symptoms and impairment, and parent 
DISC-IV interviews were used to evaluate the impact on ADHD prevalence estimates of 
different case definition criteria that might be employed in clinical practice or research 
studies. The evaluation of varying diagnostic criteria relies primarily on baseline data to 
which different case definition criteria were applied in succession to explore the impact of 
each additional criterion. Teacher evaluations were not available for follow-up assessments.
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Symptom count criteria—In the first step, to parallel research studies that rely only on 
teacher-reported symptom counts, estimates reflect rates of (a) teacher report of six or more 
symptoms, as well as estimates based on (b) the report of at least some impairment due to 
symptoms, then (c) the effect of requiring both a minimum symptom count and at least some 
impairment.
Report of diagnosis or treatment—The second step parallels surveys that rely solely 
on reported diagnosis and treatment, and reflects parent and teacher reports of ADHD 
diagnosis or treatment, separately and combined.
DSM-based estimates—The third step is patterned after DSM-IV criteria and 
successively reports proportions in the following order, each conditioned on meeting the 
prior criterion: (a) six or more parent-reported DISC-IV symptoms, (b) problem onset before 
age seven, (c) at least two moderate or one severe rating of impairment, and, finally, (d) a 
second informant (teacher) report of at least four symptoms.
At each stage results are reported as unweighted numbers with weighted percentages and 
95% confidence intervals for proportions representing the school population, and 
unweighted percentages for within-sample comparisons.
Applying DSM-5 Criteria—Age of onset and symptom count data from each participant’s 
last follow-up interview were used to estimate changes in prevalence due to DSM-5’s 
revised criteria. Consistent with DSM-5 specification of symptoms as ‘Mild’, ‘Moderate’, or 
‘Severe’, we used DISC-IV parent-reported severity of impairment associated with 
symptoms to determine the impact of requiring at least two moderate or at least one severe 
rating of impairment across six domains.
III. Results
Case Definition Parameters
Teacher screeners and baseline parent interviews were obtained for 481 children in South 
Carolina and 579 children in Oklahoma. Demographic characteristics are shown in Table 1. 
Because relative changes in estimates when applying different case definition criteria 
resulted in similar patterns in both sites, combined results are presented here. The SC sample 
had a higher proportion of Black students and the OK sample had more Hispanic and 
American Indian students, though both samples were racially diverse. The most significant 
difference between the two samples was in the proportion of students from families at less 
than 200% of the 2004 federal poverty line (<200% FPL: 67.8% in OK versus 29.5% in SC).
For the screener questions on ADHD diagnosis and medication history, there were 584 
parent reports (11 parent-only) and 1040 teacher reports (467 teacher-only). Teacher-
reported proportions were lower than parent-reported results (Figure 1). Of the subset of 
children for whom both parent and teacher screening data are available (n=573), agreement 
between parent and teacher report of either a diagnosis or medication use was good to 
excellent (SC: κ=0.88, 95% CI =0.84–0.92; OK: κ=0.67, 95% CI=0.58–0.70); combined 
κ=0.78, 95% CI=0.69–0.87), with 7.7% of children having either diagnosis or medication 
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usage reported by both parent and teacher, and 11.6% of children having diagnosis or 
medication usage reported by at least one informant. Of those with parent-reported 
diagnosis, 67.5% were reported by teachers as having a diagnosis. When parents reported 
medication, 78.5% of teachers also reported medication; 91.3% of parents reported a 
diagnosis when the teacher also reported a diagnosis; and 90.2% of parents reported 
medication when the teacher reported medication.
Teachers reported 20.5% of children had at least six ADHD inattentive or hyperactive/
impulsive symptoms, and 33.6% of children had at least some impairment based on the SDQ 
or VADTRS. When symptom count and impairment criteria were combined, the proportion 
of children who met both criteria dropped to 16.3%.
Baseline parent interview data reflected that 29.8% of children had at least six ADHD 
symptoms (Figure 2), 81.9% of whom had symptom onset by age seven years. Varying 
impairment criteria resulted in prevalence estimates ranging from 11.5% to 17.5%. Only 
three children had a severe rating in one domain with no other moderate or severe ratings, 
thus requiring at least two moderate ratings captures 99.1% (320 out of 323) of those 
meeting the impairment component of our study case definition and 98.8% (249 out of 252) 
of those with at least one severe rating.
Finally, we added the requirement of teacher report of at least four symptoms in those 
children meeting DISC-based parent-reported criteria but who were low screen. With that 
additional requirement, the prevalence estimates decrease by approximately half, from 
17.5% to 8.9% in the pathway corresponding to our case definition, quantifying the impact 
of the inclusion of information from multiple informants.
DSM-5-Based Case Definition Comparison
While 45 of 482 sample children with six or more DSM-IV ADHD symptoms did not meet 
the age of onset criterion of seven years, all but six of the children meeting symptom count 
criteria met the new age of onset criterion of 12 years (Figure 2). Adding the impairment 
criterion resulted in a greater reduction in the prevalence estimate when using the earlier age 
of onset: 28.3% reduction versus 22.6% for the later age of onset. Alternatively, 323 of 437 
with earlier symptom onset met the impairment criterion, while 396 of the 476 with onset by 
age 12 years met that additional requirement. When adding in the requirement of at least 
four teacher-reported symptoms, the weighted prevalence estimates were 8.9% based on 
DSM-IV versus 11.3% of school-aged children based on DSM-5 (Figure 2).
Of the 1,060 participants at baseline, 656 had at least one follow-up interview. Demographic 
characteristics of participants at their final PLAY follow-up assessment (age range: 7–19) 
are in Table 1, and characteristics of the case group under differing criteria in Table 2; the 
effects of modifying diagnostic criteria on prevalence estimates are shown in Figure 3. At 
follow-up the SC sample was slightly older than in OK because of additional follow-up 
interviews. In the final assessment sample 8.2% (n=128 of 656) met DISC-IV case criteria 
(95% CI: 5.9, 11.2) with 54.7% classified with the inattentive subtype. When the age of 
onset criterion is modified for symptom onset to have occurred before age 12 years rather 
than age seven, the prevalence of ADHD increases to 13.0% (95% CI: 7.6, 21.4), adding 20 
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cases, with 58.1% (16 additional) as inattentive subtype. The remaining four new cases were 
all combined subtype.
The final major change to the DSM-5 criteria allows for a decrease from six to five in the 
number of symptoms needed to qualify for diagnosis among young adults. There were 109 
participants aged 17 years or older in the last interview (n= 656), 23 (21.1%) who were 
considered cases, yielding a weighted prevalence among those aged 17 and older of 8.1% 
(95% CI: 4.1, 15.6). The required symptom count reduction resulted in only two additional 
cases (both inattentive subtype), producing a weighted prevalence in older participants of 
8.7% (95% CI: 4.4, 16.3) and a slight increase in overall prevalence of ADHD cases from 
13.0% to 13.1% (95% CI 7.7, 21.5) in the full follow-up cohort.
IV. Discussion
In spite of widely varying published estimates of the prevalence of ADHD, there has been 
very little research on the qualitative and quantitative impact of varying case definitions and 
criteria on prevalence estimates. Relying on data from a community-based cohort, we have 
examined the extent to which applying successively more rigorous criteria impact the 
resulting proportions of the study sample who meet a specific case definition. We have also 
examined the potential impact of new DSM-5 criteria on prevalence estimates.
Consistent with DSM, requiring at least some impairment decreases the estimated 
prevalence by 28.3% compared to reliance on symptom count alone. Even for research 
studies that rely only on teacher questionnaires that assess symptoms, requiring the full 
count of symptoms and a measure of impairment are important as an initial basis for 
classifying probable diagnosis or for obtaining reasonable estimates of prevalence.
In our DISC-IV parent interview data, the prevalence of suspected ADHD with onset by age 
seven dropped by about one-half when at least one severe rating of impairment was required 
versus our original definition of one severe or two moderate ratings. This highlights the 
importance of clarity in the definition of impairment and the need for guidance for both 
clinical diagnosis and research classification. It also demonstrates that the definition of 
impairment, especially regarding the level of severity required, has a large impact on the 
classification of disorder. Degree of impairment is also the most salient clinical finding, as it 
has been shown that the presence of impairment, rather than symptoms, may drive who 
seeks treatment.34 Further research on the measurement of impairment severity is crucial for 
both diagnosis and treatment of ADHD.
Because many survey-based estimates rely on parent reports of diagnosis and medication 
treatment, we examined the agreement between teacher and parent reports and the impact of 
combining rules for diagnosis or treatment and for informants. There was moderate to strong 
agreement between parents and teachers on diagnosis and medication for ADHD, with 
parent-reported rates higher than those based on teacher report, though the difference 
between parents and teachers was greater for reported diagnosis (36%) than for medication 
use (19%). Teachers may be more aware of medication treatment than of diagnoses, due to 
the marked change in behavior that is achieved with medication treatment, even with the 
emergence of extended release formulations that may be administered exclusively at home. 
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Our findings are consistent with this interpretation: teachers reported medication 78.5% of 
the time when parents reported medication, but reported a diagnosis only two-thirds of the 
time when parents reported diagnosis.
It should also be noted that parents are able to respond to whether the child has ever been 
diagnosed but teachers may be able to respond only for the period they have the child in 
class. As expected, when teachers reported diagnosis or medication, parents also reported 
over 90% of the time. That is, teacher reports appear to have good specificity, but less 
sensitivity, especially for ‘ever diagnosed’ classifications.
The results also demonstrate the importance of multiple informants in determining the 
presence of symptoms and impairment in multiple settings. Adding the requirement of at 
least four teacher-reported symptoms to the DISC-IV case definition with full parent-
reported symptoms and impairment reduced the prevalence estimate in our data by half. Our 
data support the conclusions of others that the use of a second informant is important to 
appropriate diagnosis and to valid estimates of prevalence.22,35
It should be noted, however, that DSM-5 is not explicit about the extent to which symptoms 
must be present in different settings. Though the multiple informant issue is distinct from the 
multiple settings issue, they are related in that additional informants provide information 
about the subject in other settings or relationships. These concerns are further complicated 
for older adolescents and adults, who may be the only informant at diagnosis. Attempts to 
feign symptoms in order to obtain special accommodations or prescriptions for stimulant 
medication have been documented36,37 and further reinforce the need for additional 
confirmatory reports from other informants. Thus, a clinical decision, rather than reliance on 
checklists from informants, may be most important, with multiple informants enriching the 
information available to the clinician for making diagnostic and treatment decisions. This is 
a significant issue, particularly with primary care evaluations, where the time for assessment 
is limited in most practices.
We were able to assess the potential impact of the changes in diagnostic criteria in DSM-5 
regarding age of onset and number of symptoms required for those aged 17 and older. 
Comparable to a recent U.S. study,21 but in contrast to estimates from a British birth 
cohort,38 older age of onset had a substantial impact, increasing the proportion with 
probable ADHD by 18% compared to estimates based only on symptomatology and by 27% 
after application of the impairment and second informant criteria. Given the baseline age of 
this elementary school sample, it was expected that the expanded age of onset criterion was 
not going to rule out many of the children, because most of them were younger than 12 at 
baseline. However at follow-up, when only 13.4% of the participants were under age 12, the 
extended age of onset added 20 cases resulting in an increase in prevalence from 8.2% to 
13.1%. It seems clear that the change in the age of onset criterion is likely to result in a 
substantial increase in ADHD diagnosis, the extent of which is also a function of how 
rigorously the DSM-IV criterion had been applied in practice in the past.
In our sample the reduction in symptom count from six to five for those aged 17 and older 
resulted in the addition of only two cases, both with inattentive type, in the final interview 
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follow-up sample in which 16.6% (n=109) were 17 years of age or older. Of those with five 
or more inattentive symptoms, 183 of 208 (88%) had at least six symptoms, and of those 
with five or more hyperactive-impulsive symptoms, 70 of 94 (74.5%) had at least six 
symptoms. This difference is consistent with our previous findings of greater persistence of 
inattentive versus hyperactive symptoms through adolescence.33 It does not appear that this 
relaxation of criteria for those 17 and older will have major impact for older adolescents, 
though we cannot draw any conclusions about the impact on adult populations with a 
broader age range.
This study exhibits some of the limitations common to community-based epidemiologic 
studies. Though the evaluations were conducted using validated systematic structured 
interviews (DISC-IV), with standardized algorithms and rigorous training of interviewers, 
there is potential for response bias, including social desirability and selective recall, 
especially in recalling age of onset for symptoms. The interviewed sample when weighted is 
diverse in race, ethnicity, and socioeconomic status and representative of the school districts 
from which it was drawn, but is not representative of the US population as a whole. 
Response rates were typical of contemporary epidemiologic studies – of those who 
participated at baseline, 62% had at least one follow-up interview – so there is a possibility 
of bias due to attrition. Finally, we did not have access to physician or other provider records 
to verify treatment and diagnosis, and relied only on parent and teacher reports of diagnosis, 
treatment, symptoms, impairment, and age of onset, though we believe parents to be the 
optimal informant for age of onset.
These findings quantify the impact of various DSM-based case definition criteria on 
research-based prevalence estimates, but also have implications for clinical practice because 
they indicate the influence of various criteria on the probability of valid classification. 
Changes in diagnosis may impact patterns of comorbidity in research studies as well as in 
clinical settings where treatment decisions may be affected. Further, the new criteria are 
especially likely to impact perceptions of developmental trajectories and considerations of 
the appropriateness of ADHD diagnosis in older adolescents and adults.
Assessment of impairment is a critical component of research and clinical diagnosis, and is 
most useful for diagnosis, treatment, and research when it includes both specification of the 
level of severity and consideration of multiple domains. Similarly, our findings document 
the sensitivity of prevalence estimates to both symptoms and impairment across settings, 
further supporting the importance of including reports from multiple informants. The level 
of impairment remains a matter of clinical judgment, rather than simple reliance on 
checklists from informants. Although time for assessment and access to additional 
informants in clinical settings is often limited, the determination of the extent and level of 
impairment is important, even if derived from a single informant.
We were also able to assess the probable impact of new DSM-5 criteria: the likely increase 
in prevalence from raising the required age of onset, and a possible smaller increase in 
prevalence among older adolescents and young adults due to the reduction in symptom 
count required. These findings will contribute to evaluating trends in ADHD diagnosis by 
assisting clinicians and researchers in differentiating changes due to new criteria from 
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secular changes due to trends in prevalence already documented. Because of the age of our 
participants, we are less clear about how the new criteria will impact diagnosis and estimates 
of prevalence among adults older than those in our sample.
Finally, even though multi-axial assessment is no longer part of DSM-5, it remains clinically 
important to consider environmental factors that may exacerbate symptoms and impairment 
in late-onset cases. We hope to use our longitudinal data to shed light on this little-studied 
phenomenon.
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Number and unweighted percent (95% CI) of the screened Project to Learn about Attention 
Deficit/Hyperactivity Disorder (ADHD) in Youth sample with a parent- or teacher-reported 
ADHD diagnosis or medication use
Note: Denominators reported above show the number of parents and teachers who 
responded to whether a child had been diagnosed or used medication. Likely explanations 
for more teacher-reported data include that they received incentives, they were directly 
requested to complete them by school administrators, and they were able to complete 
classroom-sized batches of instruments.
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Depreciation in the number and percent (95% CI) of the baseline Project to Learn about 
Attention Deficit/Hyperactivity Disorder (ADHD) in Youth sample who met each level of 
ADHD diagnostic criteria.
* No participants at baseline were 17 years or older, so required symptom count remains 6+.
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Change in Attention Deficit/Hyperactivity Disorder prevalence (95% CI) after incorporating 
DSM-5 changes and inclusion of teacher report.
McKeown et al. Page 16











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































McKeown et al. Page 19
Table 2
Project to Learn about Attention Deficit/Hyperactivity Disorder (ADHD) in Youth follow-up data: 
Demographics and sample characteristics (unweighted) of ADHD cases under various diagnostic criteria 
reflecting DSM-IV and DSM-5
DSM-IV criteria DSM-IV criteria + relaxing age of onset to <12 years +







Total 100.0% (128) 100.0% (22) 100.0% (150)
Sex
Male 71.1% (91) 77.3% (17) 72.0% (108)
Female 28.9% (37) 22.7% (5) 28.0% (42)
Race
White 68.0% (87) 59.1% (13) 66.7% (100)
Black 14.8% (19) 36.4% (8) 18.0% (27)
Other 17.2% (22) 4.5% (1) 15.3% (23)
Ethnicity
Hispanic 7.8% (10) 0.0% (0) 6.7% (10)
Not Hispanic 92.2% (118) 100.0% (22) 93.3% (140)
Subtype
IA 54.7% (70) 81.8% (18) 58.0% (87)
HI 7.8% (10) 0.0% (0) 6.7% (10)
Combined 37.5% (48) 18.2% (4) 35.3% (53)
Ever met criteria for a condition other than ADHD
Yes 66.4% (85) 63.6% (14) 66.0% (99)
No 33.6% (43) 36.4% (8) 34.0% (51)
Ever took ADHD medication treatment
Yes 74.2% (95) 68.2% (15) 73.3% (110)
No 25.8% (33) 31.8% (7) 26.7% (40)
SDQ Total Difficulties score
Abnormal 53.6% (67) 55.0% (11) 53.8% (78)
Borderline 20.0% (25) 15.0% (3) 19.3% (28)
Normal 26.4% (33) 30.0% (6) 26.9% (39)
Missing -- (3) -- (2) -- (5)
*
This table only includes additional cases, though there was some shifting between subtypes of cases from baseline to last follow-up interview. 
After requiring only 5+ symptoms for those who were 17+ yrs old, one ADHD-IA case became an ADHD-combined case.
IA=Inattentive; HI=Hyperactive/impulsive
SDQ=Strengths and Difficulties Questionnaire
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